The ability of immune cells—particularly CD8 + T cells—to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies. However, the factors and ...
Scientists from Tokyo University of Science, Japan, have identified a set of ‘signature’ genes that can determine whether cancer-fighting T cells will multiply or stall within the tumor. Their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results